332 related articles for article (PubMed ID: 34681023)
21. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists.
Kakavand H; Wilmott JS; Long GV; Scolyer RA
Pathology; 2016 Feb; 48(2):194-202. PubMed ID: 27020392
[TBL] [Abstract][Full Text] [Related]
22. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
23. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
Ascierto PA; Agarwala SS; Blank C; Caracò C; Carvajal RD; Ernstoff MS; Ferrone S; Fox BA; Gajewski TF; Garbe C; Grob JJ; Hamid O; Krogsgaard M; Lo RS; Lund AW; Madonna G; Michielin O; Neyns B; Osman I; Peters S; Poulikakos PI; Quezada SA; Reinfeld B; Zitvogel L; Puzanov I; Thurin M
J Transl Med; 2022 Sep; 20(1):391. PubMed ID: 36058945
[TBL] [Abstract][Full Text] [Related]
24. Single-cell transcriptomics: background, technologies, applications, and challenges.
Duhan L; Kumari D; Naime M; Parmar VS; Chhillar AK; Dangi M; Pasrija R
Mol Biol Rep; 2024 Apr; 51(1):600. PubMed ID: 38689046
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas-Challenges and Perspectives.
Kaminska B; Ochocka N; Segit P
Cells; 2021 Aug; 10(9):. PubMed ID: 34571910
[TBL] [Abstract][Full Text] [Related]
26. Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma.
Ziogas DC; Konstantinou F; Bouros S; Theochari M; Gogas H
Am J Clin Dermatol; 2021 May; 22(3):301-314. PubMed ID: 33765322
[TBL] [Abstract][Full Text] [Related]
27. Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer.
Zhu S; Zhang M; Liu X; Luo Q; Zhou J; Song M; Feng J; Liu J
Breast Cancer Res; 2023 Oct; 25(1):126. PubMed ID: 37858183
[TBL] [Abstract][Full Text] [Related]
28. Advanced Melanoma: Resistance Mechanisms to Current Therapies.
Haugh AM; Salama AKS; Johnson DB
Hematol Oncol Clin North Am; 2021 Feb; 35(1):111-128. PubMed ID: 33759769
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic control of
Wang MM; Koskela SA; Mehmood A; Langguth M; Maranou E; Figueiredo CR
Front Immunol; 2023; 14():1152228. PubMed ID: 37077920
[TBL] [Abstract][Full Text] [Related]
30. Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review.
Dummer R; Ascierto PA; Nathan P; Robert C; Schadendorf D
JAMA Oncol; 2020 Dec; 6(12):1957-1966. PubMed ID: 32970096
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
Marzagalli M; Ebelt ND; Manuel ER
Semin Cancer Biol; 2019 Dec; 59():236-250. PubMed ID: 31404607
[TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance.
Pulluri B; Kumar A; Shaheen M; Jeter J; Sundararajan S
Pharmacol Res; 2017 Sep; 123():95-102. PubMed ID: 28690075
[TBL] [Abstract][Full Text] [Related]
33. Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery.
Bai Z; Su G; Fan R
Genomics Proteomics Bioinformatics; 2021 Apr; 19(2):191-207. PubMed ID: 34000441
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis reveals the pivotal interactions between immune cells in the melanoma tumor microenvironment.
Chen J; Hu S; Wang H; Zhao T; Song Y; Zhong X; Luo Q; Xu M; He L; Chen Q; Du B; Xiao J; Wang K
Sci Rep; 2022 Jun; 12(1):10040. PubMed ID: 35710862
[TBL] [Abstract][Full Text] [Related]
35. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
Front Immunol; 2022; 13():998266. PubMed ID: 36248785
[TBL] [Abstract][Full Text] [Related]
36. Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy.
O'reilly A; Larkin J
Expert Rev Anticancer Ther; 2017 Jul; 17(7):647-655. PubMed ID: 28604130
[TBL] [Abstract][Full Text] [Related]
37. Integrated single-cell RNA sequencing and spatial transcriptomics analysis reveals the tumour microenvironment in patients with endometrial cancer responding to anti-PD-1 treatment.
Chen J; Song Y; Huang J; Wan X; Li Y
Clin Transl Med; 2024 Apr; 14(4):e1668. PubMed ID: 38649737
[No Abstract] [Full Text] [Related]
38. The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer.
Melo CM; Vidotto T; Chaves LP; Lautert-Dutra W; Reis RBD; Squire JA
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502458
[TBL] [Abstract][Full Text] [Related]
39. The tumour immune landscape and its implications in cutaneous melanoma.
Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
[TBL] [Abstract][Full Text] [Related]
40. Cancer biology deciphered by single-cell transcriptomic sequencing.
Li Y; Jin J; Bai F
Protein Cell; 2022 Mar; 13(3):167-179. PubMed ID: 34405376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
